MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Biocept Betriebsaufwand 2011-2025 | BIOC
Betriebsaufwand Jährlich Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 21.6 M | 17.6 M | 17.5 M | 16.9 M | 14.3 M | 12.4 M | 11.8 M | 5.75 M | 9.41 M | 12.3 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.6 M | 5.75 M | 14 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 19.37 | - | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 21.18 | - | $ 228 M |  China |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 0.24 | - | $ 7.04 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 39.4 | - | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 230.32 | - | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.04 | - | $ 285 M | Israel |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.52 | - | $ 1.93 M | USA |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.57 | - | $ 18.8 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
1.69 B | $ 67.57 | - | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 26.72 | - | $ 808 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
484 M | $ 19.48 | - | $ 1.05 B | USA |
 |
Celcuity
CELC
|
113 M | $ 102.25 | - | $ 4.03 B | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.2 | - | $ 102 K | USA |
 |
Myriad Genetics
MYGN
|
709 M | $ 6.48 | - | $ 587 M | USA |
 |
ENDRA Life Sciences
NDRA
|
10.8 M | $ 5.08 | - | $ 2.73 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 7.13 | - | $ 1.55 B | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 226.92 | - | $ 41.1 B | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 18.66 | - | $ 458 M | USA |
 |
Guardant Health
GH
|
226 M | $ 102.98 | - | $ 12.6 B | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Personalis
PSNL
|
44.5 M | $ 8.14 | - | $ 482 M | USA |
 |
Quidel Corporation
QDEL
|
285 M | $ 29.3 | - | $ 1.23 B | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | $ 45.37 | - | $ 10.1 B |  Niderland |
 |
RadNet
RDNT
|
1.73 B | $ 73.15 | - | $ 5.34 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 134.95 | - | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 203.66 | - | $ 10.5 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 175.94 | - | $ 19.5 B | USA |
|
Biodesix
BDSX
|
106 M | $ 6.82 | - | $ 884 M | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 253.89 | - | $ 21.3 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.15 B | $ 580.74 | - | $ 222 B | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 182.84 | - | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 688.48 | - | $ 56.8 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 66.71 | - | $ 4.62 B | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 420.1 | - | $ 30.1 B |  Schweiz |